Clinical Trial Update: An Exploratory Clinical Study of UX-DA001 in Subjects With Idiopathic Parkinson's Disease [Phase 1]

View source ↗

Summary

An exploratory Phase 1 clinical trial of UX-DA001 in idiopathic Parkinson disease is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• UX-DA001

Snippet

Sponsor: Shanghai UniXell Biotechnology Co., Ltd | Conditions: Parkinson Disease, Idiopathic | Phase 1 | Status: ENROLLING_BY_INVITATION